Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.
about
Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort.
P2860
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Final Results of the Telaprevi ...... dvanced Fibrosis or Cirrhosis.
@ast
Final Results of the Telaprevi ...... dvanced Fibrosis or Cirrhosis.
@en
type
label
Final Results of the Telaprevi ...... dvanced Fibrosis or Cirrhosis.
@ast
Final Results of the Telaprevi ...... dvanced Fibrosis or Cirrhosis.
@en
prefLabel
Final Results of the Telaprevi ...... dvanced Fibrosis or Cirrhosis.
@ast
Final Results of the Telaprevi ...... dvanced Fibrosis or Cirrhosis.
@en
P2093
P2860
P1433
P1476
Final Results of the Telaprevi ...... dvanced Fibrosis or Cirrhosis.
@en
P2093
Alessandra Mangia
Antonia Lepida
Christophe Moreno
Djamal Abdurakhmanov
Heiner Wedemeyer
Inmaculada Fernandez
Isabelle Lonjon-Domanec
Massimo Colombo
Paulo Abrao Ferreira
Ralph DeMasi
P2860
P304
P356
10.1371/JOURNAL.PONE.0138503
P407
P577
2015-09-23T00:00:00Z